Fighting Fire with Fire? An Assesment of the Potential Threats of Westerners Fighting against ISIS in Syria and Iraq
Savunma Bilimleri Dergisi · 2023
DOI: 10.17134/khosbd.1085135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Savunma Bilimleri Dergisi, 2023. Verfasst von Volkan ÖZ. Die Arbeit nennt 85 Literaturangaben.
Abstract (Originalsprache)
Since the Syrian Civil War began in 2011, tens of thousands of foreign fighters from different parts of the world have joined various armed groups in Syria and Iraq. There are three main groups of foreign fighters: Firstly, pro-ISIS foreign fighters who are associated with jihadist groups like Islamic State in Iraq and Syria (ISIS); secondly, pro-regime Shiite foreign fighters who are affiliated with the Assad government; and finally, anti-ISIS Western foreign fighters, fighting with Kurdish and Christian groups against ISIS and other jihadist groups. This study aims at assessing the potential threats that anti-ISIS Western foreign fighters may pose to international security and to their home countries. In line with this purpose, this study contributes to our recognition of anti-ISIS Western foreign fighters, conducts a threat assessment based on capabilities and intents of anti-ISIS Western foreign fighters and presents recommendations on how international organizations and Western governments should manage the issue of anti-ISIS Western foreign fighters.
Zitieren
APA
ÖZ, V. (2023). Fighting Fire with Fire? An Assesment of the Potential Threats of Westerners Fighting against ISIS in Syria and Iraq. Savunma Bilimleri Dergisi. https://doi.org/10.17134/khosbd.1085135
Vancouver
ÖZ V. Fighting Fire with Fire? An Assesment of the Potential Threats of Westerners Fighting against ISIS in Syria and Iraq. Savunma Bilimleri Dergisi. 2023. doi:10.17134/khosbd.1085135
BibTeX
@article{Z2023,
author = {ÖZ, Volkan},
title = {Fighting Fire with Fire? An Assesment of the Potential Threats of Westerners Fighting against ISIS in Syria and Iraq},
journal = {Savunma Bilimleri Dergisi},
year = {2023},
doi = {10.17134/khosbd.1085135}
}
EUVIMED